Company: CLX
Filing Date: 2025-10-07
Form Type: DEF 14A
Source: 0001552781-25-000311
Chunk: 1

Company: CLOROX CO /DE/
Filing Date: 2025-10-07
Form: DEF 14A
Chunk 1
---
 Fellow Shareholders, As lead independent director, I am pleased to share highlights from our Board’s work over the past year and how we continue to support Clorox’s long-term success on your behalf. The Board remains focused on overseeing corporate strategy and risk management as Clorox navigates a dynamic and challenging operating environment. Over the past year, we worked closely with management as the Company continued to advance its IGNITE strategy and invest in its brands, in the face of macroeconomic and geopolitical uncertainty and external headwinds. Strengthening The Board Through Strategic Refreshment A critical component of our focus on strong governance is ensuring that the Board has the right mix of skills, experience, and perspectives to guide the Company into the future. In line with this focus, in fiscal year 2025, we welcomed three new directors:

| • | Gina                                                                                    
 Boswell brings extensive leadership and operational experience with a strong background 
 in the consumer goods sector.                                                           |

| • | Stephen                                                                              
 Bratspies adds strong operational, merchandising and marketing expertise from senior 
 leadership roles in retail and the consumer packaged goods industry.                 |

| • | Pierre                                                                           
 Breber offers extensive financial and accounting expertise with broad experience 
 in strategic transformation and growth initiatives.                              |

Their expertise further strengthens our Board composition and reflects our commitment to thoughtful Board refreshment. Additionally, in recognition of his service, we would also like to extend our sincere gratitude to Spencer Fleischer who will be retiring from the Board as of the Annual Meeting. We thank him for his 10 years of service to the Company and Board. Active Board Oversight This year, we continued to prioritize key areas of oversight, including enterprise risk management, human capital and culture, and cybersecurity. The Board also worked closely with management on the Company’s key strategic initiatives, including the divestiture of our Better Health Vitamins, Minerals and Supplements business and preparation for the ERP implementation in the U.S. Clorox’s transformation efforts to evolve its portfolio and transform its ways of working are laying the foundation for long-term growth and enduring shareholder value. Fostering a People First Culture The Board also had the meaningful opportunity to engage directly with employees by participating once again in a global town hall, where I, together with our newest directors, answered questions and shared personal and professional experiences around what it means to play to win. We also review employee survey results each year to gain meaningful insight into how our people experience the Company. These perspectives guide us as we provide oversight in shaping a culture that not only